NM_001387552.1:c.4501G>A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001387552.1(ADGRL3):c.4501G>A(p.Val1501Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000322 in 1,551,614 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001387552.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADGRL3 | NM_001387552.1 | c.4501G>A | p.Val1501Ile | missense_variant | Exon 27 of 27 | ENST00000683033.1 | NP_001374481.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADGRL3 | ENST00000683033.1 | c.4501G>A | p.Val1501Ile | missense_variant | Exon 27 of 27 | NM_001387552.1 | ENSP00000507980.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152098Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000128 AC: 2AN: 156340Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 82808
GnomAD4 exome AF: 0.00000286 AC: 4AN: 1399398Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 690202
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74410
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.4279G>A (p.V1427I) alteration is located in exon 23 (coding exon 23) of the ADGRL3 gene. This alteration results from a G to A substitution at nucleotide position 4279, causing the valine (V) at amino acid position 1427 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at